Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Klára Mezei"'
Autor:
Patrick Wayne Cobb, Yong Wha Moon, Klára Mezei, István Láng, Gajanan Bhat, Shanta Chawla, Steven J. Hasal, Lee S. Schwartzberg
Publikováno v:
Cancer Medicine, Vol 9, Iss 17, Pp 6234-6243 (2020)
Abstract Eflapegrastim (Rolontis®) is a novel, long‐acting hematopoietic growth factor consisting of a recombinant human granulocyte‐colony stimulating factor (rhG‐CSF) analog conjugated to a human IgG4 Fc fragment via a short polyethylene gly
Externí odkaz:
https://doaj.org/article/88a9560255c6486fb96283aa83575700
Autor:
Jeffrey L. Vacirca, Arlene Chan, Klára Mezei, Clarence S. Adoo, Zsuzsanna Pápai, Kimberly McGregor, Meena Okera, Zsolt Horváth, László Landherr, Jerzy Hanslik, Steven J. Hager, Emad N. Ibrahim, Makharadze Rostom, Gajanan Bhat, Mi Rim Choi, Guru Reddy, Karen L. Tedesco, Richy Agajanian, István Láng, Lee S. Schwartzberg
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1660-1669 (2018)
Abstract This randomized, open‐label, active‐controlled study investigated the safety and efficacy of three doses of Rolontis (eflapegrastim), a novel, long‐acting myeloid growth factor, versus pegfilgrastim in breast cancer patients being trea
Externí odkaz:
https://doaj.org/article/1f6680c5bfb248398350b02a42dc442f
Autor:
Erika Hartmann, Zoltán Lóderer, András Vereczkei, György Lázár, Tamás Györke, György Bodoky, Zsuzsanna Papai, Péter Pajor, Oszkár Hahn, Barna Bogner, Károly Kalmár Nagy, Klára Mezei, Elemér Mohos, Zsolt Horváth, Eszter Székely, Magdolna Dank, Attila Doros, P. Á. Deák, Zsuzsa Schaff, Marianna Imre, István Sipőcz, Edit Dósa, Mihály Patyánik, László Mangel, László Harsányi, Péter Kupcsulik, I. Dudás, Péter Bartek, Kristóf Dede, András Papp, Ágnes Ruzsa, Zsolt Káposztás, József Lövey, István Battyáni, Laszlo Torday, Tamás Mersich, Attila Szijártó, Zoltan Mathe, László Sikorszki, László Damjanovich, Krisztina Schlachter, János Révész, Csilla András, Lajos Tóth, László Landherr, János Bezsilla, Erika Hitre, Tibor Csőszi, Zsófia Dankovics, Gábor István, András Palkó, Attila Bursics, András Petri, Ákos Szűcs, László Kóbori, Attila Oláh
Publikováno v:
Orvosi Hetilap. 160:2-20
Autor:
Steven J. Hasal, Lee S. Schwartzberg, Patrick Wayne Cobb, István Láng, Klára Mezei, Shanta Chawla, Yong Wha Moon, Gajanan Bhat
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 17, Pp 6234-6243 (2020)
Cancer Medicine, Vol 9, Iss 17, Pp 6234-6243 (2020)
Eflapegrastim (Rolontis®) is a novel, long‐acting hematopoietic growth factor consisting of a recombinant human granulocyte‐colony stimulating factor (rhG‐CSF) analog conjugated to a human IgG4 Fc fragment via a short polyethylene glycol linke
Autor:
Richy Agajanian, Arlene Chan, Guru Reddy, Lee S. Schwartzberg, Kimberly McGregor, István Láng, Jeffrey L. Vacirca, Meena Okera, Klára Mezei, Jerzy Hanslik, Makharadze Rostom, Mi Rim Choi, Zsolt Horváth, László Landherr, Emad N. Ibrahim, Gajanan Bhat, Clarence S. Adoo, Karen L. Tedesco, Zsuzsanna Pápai, Steven J. Hager
Publikováno v:
Cancer Medicine
This randomized, open‐label, active‐controlled study investigated the safety and efficacy of three doses of Rolontis (eflapegrastim), a novel, long‐acting myeloid growth factor, versus pegfilgrastim in breast cancer patients being treated with
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.